Table 1.
Total | All N = 128 | Untreated patients N = 110 |
---|---|---|
All susceptible | 65 (50.8%) | 60 (54.5%) |
Mono resistance | 41 (32.0%) | 34 (30.9%) |
Clarithromycin resistance only | 6 (4.7%) | 6 (5.5%) |
Metronidazole resistance only | 13 (10.2%) | 9 (8.2%) |
Levofloxacin resistance only | 21 (16.4%) | 18 (16.4%) |
Tetracycline resistance only | 1 (0.8%) | 1 (0.9%) |
Multiple resistance | 22 (17.2%) | 16 (14.5%) |
Clarithromycin + metronidazole | 3 (2.3%) | 2 (1.8%) |
Clarithromycin + levofloxacin | 9 (7.0%) | 6 (5.5%) |
Metronidazole + levofloxacin | 7 (5.5%) | 6 (5.5%) |
Clarithromycin + metronidazole + levofloxacin | 3 (2.3%) | 2 (1.8%) |